Paediatric clinical trials

Human medicines European public assessment report (EPAR): Farydak, panobinostat, Date of authorisation: 28/08/2015, Revision: 14, Status: Authorised

Information on the Member States requirement for the nomination of a pharmacovigilance (PhV) contact person at national level

In-use stability testing of veterinary medicinal products - Scientific guideline

Guideline on in-use stability testing of veterinary medicinal products

Clinical Trials Information System (CTIS): Walk-in clinic September 2025, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 24 September 2025, 16:00 (CEST) to 24 September 2025, 17:00 (CEST)

Human normal immunoglobulins

Human medicines European public assessment report (EPAR): Deferasirox Mylan, deferasirox, Date of authorisation: 26/09/2019, Revision: 11, Status: Authorised

Human medicines European public assessment report (EPAR): Zefylti, filgrastim, Date of authorisation: 12/02/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Truxima, rituximab, Date of authorisation: 17/02/2017, Revision: 26, Status: Authorised